The consortium gathered in Stockholm on 25–26 February 2025 to reflect on 2024’s achievements and exchange insights from the past year
The INTERCEPT-T2D consortium gathered in Stockholm on 25–26 February 2025 for our third meeting. Over two productive days, partners from across Europe came together to share progress on each work block, discuss emerging data, and refine plans for the year ahead.
This face-to-face exchange strengthened collaboration between clinical teams, immunologists, bioinformaticians, and investigators, ensuring alignment on clear action points.